DIA
TCRT icon

Denver Investment Advisors’s Alaunos Therapeutics TCRT Stock Holding History

Denver Investment Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-69
Closed -$112K – 608
2015
Q1 		$112K Buy
+69
New +$102K ﹤0.01% 613
2014
Q3 		– Sell
-322
Closed -$195K – 637
2014
Q2 		$195K Buy
+322
New +$179K 0.01% 551

Other funds holding TCRT

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Denver Investment Advisors's TCRT Position: Q2 2015 in Review

Denver Investment Advisors sold out of Alaunos Therapeutics (TCRT) in Q2 2015, closing a stake of 69 shares — an estimated $112K sold.

Denver Investment Advisors first reported a position in TCRT in Q2 2014 and held it in 2 quarters. The position peaked at $195K in Q2 2014. 156 funds tracked by Wall St. Rank hold TCRT as of Q2 2015.

  • Denver Investment Advisors reported no remaining Alaunos Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Denver Investment Advisors sold 69 Alaunos Therapeutics shares in Q2 2015, an estimated $112K.
  • Denver Investment Advisors first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 2 quarters.
  • Denver Investment Advisors's Alaunos Therapeutics position peaked at $195K in Q2 2014.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2015.

Based on Denver Investment Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.